Tirzepatide - 20mg

Tirzepatide 20mg – Research Peptide

Product Overview

Tirzepatide is a synthetic peptide-based compound that acts on two metabolic hormone receptors: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Its dual-receptor activity has attracted significant scientific and clinical interest in glucose metabolism, energy balance and appetite-related physiological processes.

Product Details

* Product: Tirzepatide
* Labelled quantity: 20mg
* Category: Research-use compound
* Supplier: British Peptides Co.
* Intended use: Laboratory research purposes only

Research Background

Tirzepatide has been extensively investigated for its activity at GIP and GLP-1 receptors, which are involved in glucose-dependent insulin secretion and broader metabolic regulation.

Clinical studies in specific patient populations have demonstrated effects on blood glucose control and body weight when tirzepatide is used as an authorised medicine under appropriate medical supervision. These findings have made it an important subject of research into incretin biology, metabolic health and the interaction between hormone signalling pathways.

Researchers continue to investigate the mechanisms underlying its effects, including interactions between GIP and GLP-1 receptor signalling and their contributions to metabolic outcomes.

Clinical findings relate to specific formulations, doses, populations and treatment conditions. They should not be assumed to establish the safety, quality or effectiveness of an independently supplied research product.

Quality & Product Information

British Peptides Co. aims to provide clear product identification and relevant documentation where supplied and verified. Product identity, composition, purity and batch-specific analytical results should be confirmed using applicable supplier documentation and independent analytical testing where available.